Very large hidden genetic diversity in one single tumor: evidence for tumors-in-tumor
暂无分享,去创建一个
L. Zapata | Chung-I Wu | P. Lan | Hai-jun Wen | Yongsen Ruan | Qichun Cai | Bingjie Chen | Xianrui Wu | Yulin Zhang
[1] J. Fowler,et al. Mutant clones in normal epithelium outcompete and eliminate emerging tumours , 2021, Nature.
[2] S. Ogawa,et al. Clonal expansion in non-cancer tissues , 2021, Nature Reviews Cancer.
[3] S. Loi,et al. Intratumoral heterogeneity in cancer progression and response to immunotherapy , 2021, Nature Medicine.
[4] L. Galluzzi,et al. Macrophages and Metabolism in the Tumor Microenvironment. , 2019, Cell metabolism.
[5] Xin Luo,et al. Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease , 2019, Cell.
[6] Nicolai J. Birkbak,et al. Neoantigen-directed immune escape in lung cancer evolution , 2019, Nature.
[7] J. B. Jensen,et al. Mutational analysis of field cancerization in bladder cancer , 2019, bioRxiv.
[8] M. Stratton,et al. The landscape of somatic mutation in normal colorectal epithelial cells , 2018, Nature.
[9] Peter J. Campbell,et al. Somatic mutant clones colonize the human esophagus with age , 2018, Science.
[10] Thomas O. McDonald,et al. Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution , 2018, Nature Genetics.
[11] Marc J. Williams,et al. Reply to ‘Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution’ , 2018, Nature Genetics.
[12] S. Luo,et al. High prevalence of focal and multi-focal somatic genetic variants in the human brain , 2018, Nature Communications.
[13] Xionglei He,et al. On the low reproducibility of cancer studies. , 2018, National science review.
[14] Ville Mustonen,et al. The evolutionary landscape of colorectal tumorigenesis , 2018, Nature Ecology & Evolution.
[15] Wyeth W. Wasserman,et al. Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer , 2018, Cell.
[16] A. Shaw,et al. Tumour heterogeneity and resistance to cancer therapies , 2018, Nature Reviews Clinical Oncology.
[17] Marc J. Williams,et al. Reply: Is the evolution of tumors Darwinian or non-Darwinian? , 2018 .
[18] T. Graham,et al. An evolutionary perspective on field cancerization , 2017, Nature Reviews Cancer.
[19] Xuemei Lu,et al. Is the evolution in tumors Darwinian or non-Darwinian? , 2018 .
[20] Ying Shen,et al. Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancer , 2017, Nature Communications.
[21] P. Lønning,et al. Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.
[22] Adam D. DePriest,et al. Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators. , 2017, European urology.
[23] Xuemei Lu,et al. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution , 2015, Proceedings of the National Academy of Sciences.
[24] R. Hudson,et al. Further genetic diversification in multiple tumors and an evolutionary perspective on therapeutics , 2015, bioRxiv.
[25] A. Palumbo,et al. Genetic instability in the tumor microenvironment: a new look at an old neighbor , 2015, Molecular Cancer.
[26] C. Curtis,et al. A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.
[27] Andrew Menzies,et al. Analysis of the Genetic Phylogeny of Multifocal Prostate Cancer Identifies Multiple Independent Clonal Expansions in Neoplastic and Morphologically Normal Prostate Tissue , 2015, Nature Genetics.
[28] Alexander G. Fletcher,et al. Quantification of Crypt and Stem Cell Evolution in the Normal and Neoplastic Human Colon , 2014, Cell reports.
[29] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[30] D. Shibata,et al. Direct Measurements of Human Colon Crypt Stem Cell Niche Genetic Fidelity: The Role of Chance in Non-Darwinian Mutation Selection , 2013, Front. Oncol..
[31] L. Pusztai,et al. Cancer heterogeneity: implications for targeted therapeutics , 2013, British Journal of Cancer.
[32] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[33] R. Minchin,et al. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives , 2012, EMBO molecular medicine.
[34] T. Graham,et al. Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis. , 2012, Gastroenterology.
[35] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[36] Hans Clevers,et al. Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells , 2010, Cell.
[37] S. Srivastava,et al. Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer , 2008, Modern Pathology.
[38] M. Weiser,et al. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[40] John Cairns,et al. Mutation selection and the natural history of cancer , 1975, Nature.